Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000054947 | SCV000478221 | uncertain significance | Tuberous sclerosis syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000393416 | SCV000478222 | uncertain significance | Isolated focal cortical dysplasia type II | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000563693 | SCV000664631 | likely benign | Hereditary cancer-predisposing syndrome | 2016-03-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000642084 | SCV000763737 | likely benign | Tuberous sclerosis 1 | 2025-01-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000642084 | SCV002040086 | likely benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000563693 | SCV002530938 | likely benign | Hereditary cancer-predisposing syndrome | 2021-08-27 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV000054947 | SCV004832461 | likely benign | Tuberous sclerosis syndrome | 2024-05-30 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000054947 | SCV000083163 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation | ||
Prevention |
RCV004745183 | SCV005345653 | likely benign | TSC1-related disorder | 2024-04-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |